ESR1 and neoplasm: Other patient-, tumor-, and treatment-related characteristics were observed to have an impact on clinical outcome, such as age, tumor grade, comedo-type necrosis, close or involved margins, estrogen (ER) and progesteron (PgR) receptor status, and administration of endocrine therapy [14,15,16,17].